Hims & Hers Health
S&P 400
$27.51
+0.26%
Delayed · cached 15 min
Fair value analysis
HIMS
Hims & Hers Health
$27.51
Close used for this calculation
$5.90Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
39/100
Quality radar
Consensus fair value
$5.90
Above FV▼ -78.6% against the close used
Model range $1.92 – $10.20
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$1.92Fair value$5.90Bull$10.20
FairClose
52-week traded range
52W low $14.5252W high $62.76
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Hims & Hers Health closed at $27.51, 366.3% above the consensus fair value of $5.90 drawn from 7 valuation models.
Financial DNA score 39/100 — Average. P/E of 53.9x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$4.27
-84.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
$10.20
-62.9%
EPS × 20x (sector P/E)
EPS=0.51, Sector P/E=20x
Peter Lynch (PEG)
$1.92
-93.0%
EPS × Growth% (PEG = 1 is fair)
EPS=0.51, g=3.8%
EV/EBITDA
$6.36
-76.9%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=160.12M
Book Value (P/B)
$7.32
-73.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1.4, ROE=39.6%, g=3%, r=10%
Reverse DCF
$27.51
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 20.6% | Historical: -3.8%
Margin of Safety
$5.43
-80.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=7.23, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.